Marik, Anikó Rita http://orcid.org/0000-0002-9504-6487
Miklós, Ildikó http://orcid.org/0009-0004-4777-7471
Csukly, Gábor http://orcid.org/0000-0002-5006-9407
Hársfalvi, Péter http://orcid.org/0000-0002-6048-5017
Novák, András http://orcid.org/0009-0000-4463-1101
Funding for this research was provided by:
Egis Pharmaceuticals PLC
Article History
Accepted: 28 April 2024
First Online: 16 May 2024
Declarations
:
: The study was conducted in accordance with local legislations and the Medical Device Regulation as a post-marketing clinical follow-up study, underwent positive ethical appraisal by the Committee of Science and Research of the Medical Research Council, and received approval from the National Institute of Pharmacy and Nutrition (OGYÉI) in Hungary.
: This study was funded by Egis Pharmaceuticals PLC. Medical writing assistance for this publication was funded by Servier. Authors AN, GC, and PH declare that this publication was created in the absence of any commercial or financial relationships that could be construed as potential conflicts of interest. Authors GC and PH are affiliated with Bitrial Clinical Research Kft., the CRO conducting the study. AN participated in the study as a Coordinating Principal Investigator for which an honorarium was received. ARM and IM are employees of Egis Pharmaceuticals PLC.